Search Results - "Roses, Allen"

Refine Results
  1. 1

    Pharmacogenetics in drug discovery and development: a translational perspective by Roses, Allen D

    Published in Nature reviews. Drug discovery (01-10-2008)
    “…The association of genetic profiles to drug response is helping to expedite the development of new drugs and diagnostic tests. Roses discusses the…”
    Get full text
    Journal Article
  2. 2

    Pharmacogenetics and drug development: the path to safer and more effective drugs by Roses, Allen D

    Published in Nature reviews. Genetics (01-09-2004)
    “…Pharmacogenetics provides opportunities for informed decision-making along the pharmaceutical pipeline. There is a growing literature of retrospective studies…”
    Get full text
    Journal Article
  3. 3

    Pharmacogenetics and the practice of medicine by Roses, Allen D

    Published in Nature (London) (15-06-2000)
    “…"If it were not for the great variability among individuals medicine might as well be a science and not an art." The thoughts of Sir William Osler in 1892…”
    Get full text
    Journal Article
  4. 4

    CAP—advancing the evaluation of preclinical Alzheimer disease treatments by Reiman, Eric M., Langbaum, Jessica B., Tariot, Pierre N., Lopera, Francisco, Bateman, Randall J., Morris, John C., Sperling, Reisa A., Aisen, Paul S., Roses, Allen D., Welsh-Bohmer, Kathleen A., Carrillo, Maria C., Weninger, Stacie

    Published in Nature reviews. Neurology (01-01-2016)
    “…The term 'preclinical Alzheimer disease (AD) treatment' refers to interventions that are initiated in cognitively unimpaired at-risk individuals, and are…”
    Get full text
    Journal Article
  5. 5

    The Alu neurodegeneration hypothesis: A primate-specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative disease by Larsen, Peter A, Lutz, Michael W, Hunnicutt, Kelsie E, Mihovilovic, Mirta, Saunders, Ann M, Yoder, Anne D, Roses, Allen D

    Published in Alzheimer's & dementia (01-07-2017)
    “…Abstract It is hypothesized that retrotransposons have played a fundamental role in primate evolution and that enhanced neurologic retrotransposon activity in…”
    Get full text
    Journal Article
  6. 6

    The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease by Zeitlow, Kahli, Charlambous, Lefko, Ng, Isaac, Gagrani, Sonal, Mihovilovic, Mirta, Luo, Shuhong, Rock, Daniel L., Saunders, Ann, Roses, Allen D., Gottschalk, W. Kirby

    “…A variable-length poly-T variant in intron 6 of the TOMM40 gene, rs10524523, is associated with risk and age-of-onset of sporadic (late-onset) Alzheimer's…”
    Get full text
    Journal Article
  7. 7

    The Medical and Economic Roles of Pipeline Pharmacogenetics: Alzheimer's Disease as a Model of Efficacy and HLA-B5701 as a Model of Safety by Roses, Allen D

    Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2009)
    “…Pharmacogenetics (PGX) is the study of drug response as a function of an individual's DNA. PGX is often viewed as an extension of disease association genetics,…”
    Get full text
    Journal Article
  8. 8

    TOMM40′523 variant and cognitive decline in older persons with APOE ε3/3 genotype by Yu, Lei, Lutz, Michael W, Wilson, Robert S, Burns, Daniel K, Roses, Allen D, Saunders, Ann M, Gaiteri, Chris, De Jager, Philip L, Barnes, Lisa L, Bennett, David A

    Published in Neurology (14-02-2017)
    “…OBJECTIVE:To interrogate a poly-T variant (rs10524523, ′523) in TOMM40, a gene adjacent to the APOE gene on chromosome 19, in older persons with APOE ε3/3…”
    Get full text
    Journal Article
  9. 9

    New applications of disease genetics and pharmacogenetics to drug development by Roses, Allen D, Saunders, Ann M, Lutz, Michael W, Zhang, Nanyin, Hariri, Ahmad R, Asin, Karen E, Crenshaw, Donna G, Budur, Kumar, Burns, Daniel K, Brannan, Stephen K

    Published in Current opinion in pharmacology (01-02-2014)
    “…Highlights • A variable polyT variation within TOMM40 was associated with MCI-AD. • TOMM40 genotypes are 97% informative for estimating age of onset risk. •…”
    Get full text
    Journal Article
  10. 10

    The effects of PPARγ on the regulation of the TOMM40-APOE-C1 genes cluster by Subramanian, Shobana, Gottschalk, William K., Kim, So Young, Roses, Allen D., Chiba-Falek, Ornit

    “…Chromosome 19q13.32 is a gene rich region, and has been implicated in multiple human phenotypes in adulthood including lipids traits, Alzheimer's disease, and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Effects of low doses of pioglitazone on resting-state functional connectivity in conscious rat brain by Crenshaw, Donna G, Asin, Karen, Gottschalk, William K, Liang, Zhifeng, Zhang, Nanyin, Roses, Allen D

    Published in PloS one (11-02-2015)
    “…Pioglitazone (PIO) is a peroxisome proliferator-activated receptor-γ (PPARγ) agonist in clinical use for treatment of type 2 diabetes (T2DM). Accumulating…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The SSV Evaluation System: A Tool to Prioritize Short Structural Variants for Studies of Possible Regulatory and Causal Variants by Saul, Robert, Lutz, Michael W., Burns, Daniel K., Roses, Allen D., Chiba-Falek, Ornit

    Published in Human mutation (01-09-2016)
    “…ABSTRACT Short structural variants (SSVs) are short genomic variants (<50 bp) other than SNPs. It has been suggested that SSVs contribute to many human complex…”
    Get full text
    Journal Article
  16. 16

    Characterization of the poly-T variant in the TOMM40 gene in diverse populations by Linnertz, Colton, Saunders, Ann M, Lutz, Michael W, Crenshaw, Donna M, Grossman, Iris, Burns, Daniel K, Whitfield, Keith E, Hauser, Michael A, McCarthy, Jeanette J, Ulmer, Megan, Allingham, Rand, Welsh-Bohmer, Kathleen A, Roses, Allen D, Chiba-Falek, Ornit

    Published in PloS one (16-02-2012)
    “…We previously discovered that a polymorphic, deoxythymidine-homopolymer (poly-T, rs10524523) in intron 6 of the TOMM40 gene is associated with age-of-onset of…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease by Roses, Allen D

    Published in Journal of Alzheimer's disease (01-01-2006)
    “…The association of Apolipoprotein E-4 with the age of onset of common late-onset Alzheimer's disease (AD) was originally reported in three 1993 papers from the…”
    Get more information
    Journal Article
  20. 20